A global standard bearer in basic and applied research to vanquish cancer
IRIC, located in the heart of the Université de Montréal campus, operates according to a unique model in Canada that combines, under one roof, fundamental research activities, a university-level training program and a research maturation team. These generate discoveries that advance knowledge or that can quickly translate into new therapeutic solutions.
Researchers at UdeM have discovered a molecular process implicated in the action of anti-leukemia drugs, opening new avenues for the development of effective treatments for this disease.
On June 20, 2019, Trang Hoang, Principal Investigator at IRIC, was appointed Officer of the Ordre national du Québec. The honorary decoration, awarded by Premier François Legault, is the greatest distinction handed out by the Government of Quebec, paying tribute to exceptional people who have done outstanding work for the province.
IRIC has been awarded a 10-million dollar grant from the government of Quebec’s Fonds d’accélération des collaborations en santé (FACS), to develop new cancer-fighting drugs in collaboration with biopharmaceutical company Bristol-Myers Squibb and collaborators from seven academic research centres from Quebec and abroad.
2—6 June, 2019
From June 2 to June 5, 2019, IRIC hosted the largest conference ever held there: the 62nd Annual Conference of the Canadian Society for Molecular Biosciences (CSMB) – Model Systems in Cancer Research.
May 29, 2019
For its 6th edition, Audacious celebrated the strength of collaborations, embodied by the work of Susan McPeak and Anne Marinier, who personify the mobilizing power of a concerted effort in the fight against cancer.
Bisaillon R, Moison C, Thiollier C, Krosl J, Bordeleau ME, Lehnertz B, Lavallée VP, MacRae T, Mayotte N, Labelle C, Boucher G, Spinella JF, Boivin I, D’Angelo G, Lavallée S, Marinier A, Lemieux S, Hébert J, Sauvageau G
Leukemia
2019-07-12
;.
Baccelli I, Gareau Y, Lehnertz B, Gingras S, Spinella JF, Corneau S, Mayotte N, Girard S, Frechette M, Blouin-Chagnon V, Leveillé K, Boivin I, MacRae T, Krosl J, Thiollier C, Lavallée VP, Kanshin E, Bertomeu T, Coulombe-Huntington J, St-Denis C, Bordeleau ME, Boucher G, Roux PP, Lemieux S, Tyers M, Thibault P, Hébert J, Marinier A, Sauvageau G
Cancer Cell
2019-07-08
;36(
1
):84-99.e8.
